I think we will see enough developments to get us to a 100-200 million dollar market cap by the end of the year, with 50-100 million shares outstanding. So my share price prediction is between $1 and $4 by year end. Like everyone, I'm hoping for that $45 price target to come true, but let's be serious. It looks like we will easily hit at least 50 million outstanding shares this year and at $45 a share that values us over 2 billion, not that I would complain.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links